SMAD2 and metabolic dysfunction-associated steatohepatitis: Yang et al. reported that in Smad2-silenced cells in mice, gene expression related to lipogenesis was suppressed and gene expression related to β-oxidation was increased when Smad2 was inactivated by using an animal model of nonalcoholic steatohepatitis, one of the hepatic manifestations of MetS12.